These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35802867)

  • 21. Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis.
    Dorraji SE; Hovd AK; Kanapathippillai P; Bakland G; Eilertsen GØ; Figenschau SL; Fenton KA
    Sci Rep; 2018 May; 8(1):7861. PubMed ID: 29777158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.
    Gu F; Wang D; Zhang H; Feng X; Gilkeson GS; Shi S; Sun L
    Clin Rheumatol; 2014 Nov; 33(11):1611-9. PubMed ID: 25119864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JAK-STAT signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients.
    Ji J; Wu Y; Meng Y; Zhang L; Feng G; Xia Y; Xue W; Zhao S; Gu Z; Shao X
    Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):208-215. PubMed ID: 28177455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Mesenchymal Stem Cell Therapy on Lupus Nephritis and Renal Function in Systemic Lupus Erythematosus: A Meta-Analysis.
    Xia Y; Ye H; Li K; Shi B; Sun X; Wu J
    Clin Invest Med; 2023 Mar; 46(1):E24-35. PubMed ID: 36966389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials.
    Tappenbeck N; Schröder HM; Niebergall-Roth E; Hassinger F; Dehio U; Dieter K; Kraft K; Kerstan A; Esterlechner J; Frank NY; Scharffetter-Kochanek K; Murphy GF; Orgill DP; Beck J; Frank MH; Ganss C; Kluth MA
    Cytotherapy; 2019 May; 21(5):546-560. PubMed ID: 30878384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway.
    Gu Z; Tan W; Feng G; Meng Y; Shen B; Liu H; Cheng C
    Mol Cell Biochem; 2014 Feb; 387(1-2):27-37. PubMed ID: 24130040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.
    Wilson JG; Liu KD; Zhuo H; Caballero L; McMillan M; Fang X; Cosgrove K; Vojnik R; Calfee CS; Lee JW; Rogers AJ; Levitt J; Wiener-Kronish J; Bajwa EK; Leavitt A; McKenna D; Thompson BT; Matthay MA
    Lancet Respir Med; 2015 Jan; 3(1):24-32. PubMed ID: 25529339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined mesenchymal stem cells and allogenic bone marrow transplantation in treatment of MRL/lpr mice].
    Zhang GF; Zhang X; Dong GF
    Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):754-7. PubMed ID: 19080203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
    Kol A; Wood JA; Carrade Holt DD; Gillette JA; Bohannon-Worsley LK; Puchalski SM; Walker NJ; Clark KC; Watson JL; Borjesson DL
    Stem Cell Res Ther; 2015 Apr; 6(1):73. PubMed ID: 25888916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.
    Youd M; Blickarz C; Woodworth L; Touzjian T; Edling A; Tedstone J; Ruzek M; Tubo R; Kaplan J; Lodie T
    Clin Exp Immunol; 2010 Jul; 161(1):176-86. PubMed ID: 20456409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem/stromal cells.
    Nguyen LT; Hoang DM; Nguyen KT; Bui DM; Nguyen HT; Le HTA; Hoang VT; Bui HTH; Dam PTM; Hoang XTA; Ngo ATL; Le HM; Phung NY; Vu DM; Duong TT; Nguyen TD; Ha LT; Bui HTP; Nguyen HK; Heke M; Bui AV
    Stem Cells Transl Med; 2021 Sep; 10(9):1266-1278. PubMed ID: 34080789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II).
    Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Núñez-Córdoba JM; López-Elío S; Andreu E; Sánchez-Guijo F; Aquerreta JD; Bondía JM; Valentí-Azcárate A; Del Consuelo Del Cañizo M; Villarón EM; Valentí-Nin JR; Prósper F
    J Transl Med; 2018 Jul; 16(1):213. PubMed ID: 30064455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy.
    Pastor JC; Pastor-Idoate S; López-Paniagua M; Para M; Blazquez F; Murgui E; García V; Coco-Martín RM
    Stem Cell Res Ther; 2023 Sep; 14(1):261. PubMed ID: 37735668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).
    Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Nuñez-Córdoba JM; Sánchez-Echenique C; Bondía JM; Aquerreta JD; Andreu EJ; Ornilla E; Villarón EM; Valentí-Azcárate A; Sánchez-Guijo F; Del Cañizo MC; Valentí-Nin JR; Prósper F
    J Transl Med; 2016 Aug; 14(1):246. PubMed ID: 27565858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
    Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
    Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis.
    Ma H; Liu C; Shi B; Zhang Z; Feng R; Guo M; Lu L; Shi S; Gao X; Chen W; Sun L
    EBioMedicine; 2018 Jun; 32():21-30. PubMed ID: 29885865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of Neuropsychiatric Comorbidities in an Animal Model of Temporal Lobe Epilepsy Following Systemic Administration of Dental Pulp Stem Cells and Bone Marrow Mesenchymal Stem Cells.
    Senthilkumar S; Maiya K; Jain NK; Mata S; Mangaonkar S; Prabhu P; Rai KS; Kutty BM; Dhanushkodi A
    Curr Gene Ther; 2023; 23(3):198-214. PubMed ID: 36305152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development.
    Jang E; Jeong M; Kim S; Jang K; Kang BK; Lee DY; Bae SC; Kim KS; Youn J
    Cell Transplant; 2016; 25(1):1-15. PubMed ID: 25975931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.